A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee

Completed · Phase 3 · Has a placebo group

Conditions studied: Osteoarthritis Pain of the Knee

In brief

A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) Pain of the Knee

Key facts

Study ID
NCT04683627
Run by
Noven Pharmaceuticals, Inc.
People needed
370
Starts
2020-12-29
Expected to finish
2022-07-25
Last updated by the study team
2025-09-04

Who can join

Age: 40 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.